| 1 |
Patel GK, Prajapati B, Pathak Y. Niosomes in Malaria. Malarial Drug Delivery Systems 2023. [DOI: 10.1007/978-3-031-15848-3_12] [Reference Citation Analysis]
|
| 2 |
San Anselmo M, Lantero E, Avalos-Padilla Y, Bouzón-Arnáiz I, Ramírez M, Postigo A, Serrano JL, Sierra T, Hernández-Ainsa S, Fernàndez-Busquets X. Heparin-Coated Dendronized Hyperbranched Polymers for Antimalarial Targeted Delivery. ACS Appl Polym Mater 2023;5:381-90. [PMID: 36686062 DOI: 10.1021/acsapm.2c01553] [Reference Citation Analysis]
|
| 3 |
Trinh TT, Yun SY, Bae GJ, Moon K, Hong H, Eum TH, Kim YA, Kim SA, Park H, Kim HS, Yeo SJ. Anti-malarial activity of HCl salt of SKM13 (SKM13-2HCl). Int J Parasitol Drugs Drug Resist 2022;20:113-20. [PMID: 36375338 DOI: 10.1016/j.ijpddr.2022.10.006] [Reference Citation Analysis]
|
| 4 |
Chaves JB, Portugal Tavares de Moraes B, Regina Ferrarini S, Noé da Fonseca F, Silva AR, Gonçalves-de-albuquerque CF. Potential of nanoformulations in malaria treatment. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.999300] [Reference Citation Analysis]
|
| 5 |
Zwayen S, Zwain T, Singh KK. Targeted Drug Delivery for Antimalarial Therapy. Drug Development for Malaria 2022. [DOI: 10.1002/9783527830589.ch4] [Reference Citation Analysis]
|
| 6 |
Liu J, Ding H, Zhao M, Tu F, He T, Zhang L, Jing Y, Rui X, Zhang S. Functionalized Erythrocyte Membrane-Coated Nanoparticles for the Treatment of Klebsiella pneumoniae-Induced Sepsis. Front Microbiol 2022;13:901979. [DOI: 10.3389/fmicb.2022.901979] [Reference Citation Analysis]
|
| 7 |
Jha S, Deshmukh R, Trivedi V. Approaches and molecular tools for targeted drug delivery in malaria infected red blood cells. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases 2022. [DOI: 10.1016/b978-0-323-85873-1.00014-9] [Reference Citation Analysis]
|
| 8 |
Guasch-Girbau A, Fernàndez-Busquets X. Review of the Current Landscape of the Potential of Nanotechnology for Future Malaria Diagnosis, Treatment, and Vaccination Strategies. Pharmaceutics 2021;13:2189. [PMID: 34959470 DOI: 10.3390/pharmaceutics13122189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Patra S, Singh M, Wasnik K, Pareek D, Gupta PS, Mukherjee S, Paik P. Polymeric Nanoparticle Based Diagnosis and Nanomedicine for Treatment and Development of Vaccines for Cerebral Malaria: A Review on Recent Advancement. ACS Appl Bio Mater 2021;4:7342-65. [PMID: 35006689 DOI: 10.1021/acsabm.1c00635] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 10 |
Rashidzadeh H, Tabatabaei Rezaei SJ, Adyani SM, Abazari M, Rahamooz Haghighi S, Abdollahi H, Ramazani A. Recent advances in targeting malaria with nanotechnology-based drug carriers. Pharm Dev Technol 2021;26:807-23. [PMID: 34190000 DOI: 10.1080/10837450.2021.1948568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Neves Borgheti-Cardoso L, San Anselmo M, Lantero E, Lancelot A, Serrano JL, Hernández-Ainsa S, Fernàndez-Busquets X, Sierra T. Promising nanomaterials in the fight against malaria. J Mater Chem B 2020;8:9428-48. [PMID: 32955067 DOI: 10.1039/d0tb01398f] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 12 |
Idiago-lópez J, Moreno-antolín E, de la Fuente JM, Fratila RM. Nanoparticles and bioorthogonal chemistry joining forces for improved biomedical applications. Nanoscale Adv 2021;3:1261-92. [DOI: 10.1039/d0na00873g] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 13 |
Jaromin A, Parapini S, Basilico N, Zaremba-Czogalla M, Lewińska A, Zagórska A, Walczak M, Tyliszczak B, Grzeszczak A, Łukaszewicz M, Kaczmarek Ł, Gubernator J. Azacarbazole n-3 and n-6 polyunsaturated fatty acids ethyl esters nanoemulsion with enhanced efficacy against Plasmodium falciparum. Bioact Mater 2021;6:1163-74. [PMID: 33134609 DOI: 10.1016/j.bioactmat.2020.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 14 |
Vinaud MC, Real D, Fraga CM, Lima NF, Souza Lino Junior R, Leonardi D, J Salomon C. Nanodelivery of nitazoxanide: impact on the metabolism of Taenia crassiceps cysticerci intracranially inoculated in mice. Ther Deliv 2020;11:329-39. [PMID: 32486970 DOI: 10.4155/tde-2020-0017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 15 |
Deda DK, Iglesias BA, Alves E, Araki K, Garcia CRS. Porphyrin Derivative Nanoformulations for Therapy and Antiparasitic Agents. Molecules 2020;25:E2080. [PMID: 32365664 DOI: 10.3390/molecules25092080] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 16 |
Valissery P, Thapa R, Singh J, Gaur D, Bhattacharya J, Singh AP, Dhar SK. Potent in vivo antimalarial activity of water-soluble artemisinin nano-preparations. RSC Adv 2020;10:36201-36211. [DOI: 10.1039/d0ra05597b] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Puttappa N, Yamjala K, S. T. N, Raman SK, Kuppusamy G, Babu B, Kumar PR. A simple sensitive UFLC-MS/MS method for the simultaneous quantification of artesunate, dihydroartemisinin and quercetin in rat plasma and its application to pharmacokinetic studies. RSC Adv 2019;9:41794-802. [DOI: 10.1039/c9ra07707c] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
